Reminder of important clinical lesson: Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment

doi:10.1136/bcr.11.2009.2457

BMJ Case Rep. 2010; 2010: bcr11.2009.2457.

Published online 2010 May 6. doi: 10.1136/bcr.11.2009.2457

PMCID: PMC3047492

Reminder of important clinical lesson

Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment

Peter Denzil Correa,¹ Raj Kumar Shrimali,¹ Sai Han,² and Mohammed Rizwanullah¹

¹Beatson West of Scotland Cancer Centre, Clinical Oncology, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN, UK

²West of Scotland PET Centre, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN, UK

Correspondence to Raj Kumar Shrimali, Email: dr_shrimali/at/hotmail.com

Abstract

A case of solitary bone metastasis from breast cancer, where MRI assessment of treatment response was inaccurate and whole-body fluorodeoxyglucose (¹⁸FDG) positron emission tomography with computed tomography (PET-CT) proved more reliable and objective, is presented.

Articles from BMJ Case Reports are provided here courtesy of
BMJ Group